申请人:Pharmacyclics, Inc.
公开号:US20140079690A1
公开(公告)日:2014-03-20
Described herein are irreversible Btk inhibitor compounds, and methods for using such irreversible inhibitors in the treatment of diseases and disorders characterized by the presence or development of solid tumors.
本文描述了不可逆的Btk
抑制剂化合物,以及使用这种不可逆
抑制剂治疗由实体瘤存在或发展所特征的疾病和障碍的方法。